DeborahAnnSmithMD

PubMed

• Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid Malignancies.
  Olmos, D., Barker, D., Sharma, R., Brunetto, A.T., Yap, T.A., Taegtmeyer, A.B., Barriuso, J., Medani, H., Degenhardt, Y.Y., Allred, A.J., Smith, D.A., Murray, S.C., La...> ;Clin Cancer Res. 2011 May 15
• Two-Component Mediated Peroxide Sensing and Signal Transduction in Fission Yeast.
  Quinn, J., Malakasi, P., Smith, D.A., Cheetham, J., Buck, V., Millar, J.A., Morgan, B.A.> ;Antioxid Redox Signal. 2011 Jul 1
• Thioredoxin regulates multiple hydrogen peroxide-induced signaling pathways in Candida albicans.
  da Silva Dantas, A., Patterson, M.J., Smith, D.A., Maccallum, D.M., Erwig, L.P., Morgan, B.A., Quinn, J.> ;Mol Cell Biol. 2010 Oct
• A phase I and pharmacokinetic study of oral lapatinib administered once or twice daily in patients with solid malignancies.
  Burris, H.A., Taylor, C.W., Jones, S.F., Koch, K.M., Versola, M.J., Arya, N., Fleming, R.A., Smith, D.A., Pandite, L., Spector, N., Wilding, G.> ;Clin Cancer Res. 2009-11-01
• Effectiveness, challenges, and perceptions of classroom participation systems.
  Smith, D.A., Rosenkoetter, M.M.> ;Nurse Educ. 2009-07-01
• Effects of ketoconazole and carbamazepine on lapatinib pharmacokinetics in healthy subjects.
  Smith, D. A.,Koch, K. M.,Arya, N.,Bowen, C. J.,Herendeen, J. M.,Beelen, A.> ;Br J Clin Pharmacol. 2009 Apr 18
• A single MAPKKK regulates the Hog1 MAPK pathway in the pathogenic fungus Candida albicans.
  Cheetham, J., Smith, D.A., da Silva Dantas, A., Doris, K.S., Patterson, M.J., Bruce, C.R., Quinn, J.> ;Mol Biol Cell. 2007 Nov
• Phase I and pharmacokinetic study of lapatinib in combination with capecitabine in patients with advanced solid malignancies.
  Chu, Q.C., Schwartz, G., de Bono, J., Smith, D.A., Koch, K.M., Versola, M.J., Pandite, L., Arya, N., Curtright, J., Fleming, R.A., Ho, P.C., Rowinsky, E.K.> ;J Clin Oncol. 2007 Aug 20
• Phase I pharmacokinetic study of the safety and tolerability of lapatinib (GW572016) in combination with oxaliplatin/fluorouracil/leucovorin (FOLFOX4) in patients with...
  Siegel-Lakhai, W.S., Beijnen, J.H., Vervenne, W.L., Boot, H., Keessen, M., Versola, M., Koch, K.M., Smith, D.A., Pandite, L., Richel, D.J., Schellens, J.M.> ;Clin Cancer Res. 2007 Aug 1
• Role of the Hog1 stress-activated protein kinase in the global transcriptional response to stress in the fungal pathogen Candida albicans.
  Enjalbert, B., Smith, D.A., Cornell, M.J., Alam, I., Nicholls, S., Brown, A.P., Quinn, J.> ;Mol Biol Cell. 2006 Feb
• Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases...
  > ;J Clin Oncol. 2005 Aug 10
• Study of the biologic effects of lapatinib, a reversible inhibitor of ErbB1 and ErbB2 tyrosine kinases, on tumor growth and survival pathways in patients with advanced...
  > ;J Clin Oncol. 2005 Apr 10
• The Srk1 protein kinase is a target for the Sty1 stress-activated MAPK in fission yeast.
  Smith, D.A., Toone, W.M., Chen, D., Bahler, J., Jones, N., Morgan, B.A., Quinn, J.> ;J Biol Chem. 2002 Sep 6
• Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumors.
  Adjei, A.A., Reid, J.M., Diasio, R.B., Sloan, J.A., Smith, D.A., Rubin, J., Pitot, H.C., Alberts, S.R., Goldberg, R.M., Hanson, L.J., Atherton, P., Ames, M.M., Erlichm...> ;J Clin Oncol. 2002 Mar 15
• A Flex-Model for long-term assessment of community-residing older adults following disasters.
  Rosenkoetter, M. M.,McDonough, J.,McCall, A.,Smith, D.,Looney, S.> ;J Emerg Manag. 2015 Nov 06
• Lapatinib Plasma and Tumor Concentrations and Effects on HER Receptor Phosphorylation in Tumor.
  Spector, N. L.,Robertson, F. C.,Bacus, S.,Blackwell, K.,Smith, D. A.,Glenn, K.,Cartee, L.,Harris, J.,Kimbrough, C. L.,Gittelman, M.,Avisar, E.,Beitsch, P.,Koch, K. M.> ;PLoS ONE. 2015 Nov 17
• Video analysis tool system: implementation and evaluation of use with clinical nursing assessments of older adults.
  Rosenkoetter, M. M.,Smith, D.,Stachura, M. E.,McDonough, J.,Hunter, C.,Thompson, D.,Richter, S.,Jones, G.> ;Nurs Adm Q. 2014 Sep 11
• Embracing the tools of technology.
  Rosenkoetter, M. M.,Smith, D.> ;Nurs Adm Q. 2014 Jun 05
• Join now to see all